Glutathione – 1500 MG
Glutathione is an endogenous tripeptide first characterized by Frederick Gowland Hopkins in 1921, and is now recognized in the literature as the body’s primary intracellular antioxidant.
Each vial ships with 1,500mg of Glutathione in lyophilized powder form for reconstitution, sealed for research use, backed by Phantom Peptides’ internal verification standard: independent third-party lab analysis.
Product Specifications
- Compound: Glutathione (L-Glutathione, reduced form / GSH)
- Class: Endogenous tripeptide (antioxidant)
- Sequence: γ-Glu-Cys-Gly (gamma-glutamyl linkage)
- Molecular Weight: ~307.32 Da
- Form: Lyophilized powder (for reconstitution)
- Bottle Size: 1,500mg per vial
Research Background
The existing literature on glutathione spans a handful of distinct research threads:
- Redox biology research: cell and animal model studies examining the GSH/GSSG ratio and glutathione’s role in maintaining intracellular redox homeostasis
- Detoxification research: studies on hepatic phase II conjugation and glutathione’s role in xenobiotic and heavy metal clearance pathways
- Immune function research: cell studies examining glutathione’s role in lymphocyte proliferation and immune cell regulation
- Mitochondrial and oxidative stress research: studies on mitochondrial glutathione pools in models of oxidative damage and cellular senescence
Glutathione’s status as the primary endogenous antioxidant has made it a mainstay of biochemistry, toxicology, dermatology, and gerontology research literature. For primary sources, PubMed (pubmed.ncbi.nlm.nih.gov) and NIH’s PMC database (pmc.ncbi.nlm.nih.gov) index the peer reviewed literature on glutathione and related antioxidant research.
